title: Brain cancer prognosis: independent validation of a clinical bioinformatics approach.
abstract: Translational and evidence based medicine can take advantage of biotechnology advances that offer a fast growing variety of high-throughput data for screening molecular activities of genomic, transcriptional, post-transcriptional and translational observations. The clinical information hidden in these data can be clarified with clinical bioinformatics approaches. We have recently proposed a method to analyze different layers of high-throughput (omic) data to preserve the emergent properties that appear in the cellular system when all molecular levels are interacting. We show here that this method applied to brain cancer data can uncover properties (i.e. molecules related to protective versus risky features in different types of brain cancers) that have been independently validated as survival markers, with potential important application in clinical practice.
authors.affiliation: Key Laboratory of Computational Biology, MPG-CAS PICB, Shanghai, China. christine@picb.ac.cn.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Fronza
authors.forename: Michele
authors.initials: M
authors.lastname: Tramonti
authors.forename: William R
authors.initials: WR
authors.lastname: Atchley
authors.forename: Christine
authors.initials: C
authors.lastname: Nardini